Kiran Mahajan

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 10

Top Topics

Benign Prostatic Hyperplasia

Computed Tomography

Histone Deacetylase

Dna Damage Response

Top Venues

Clinical cancer research : an official journal of the American Association for Cancer Research

Science translational medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Nimrod S Barashi, Tiandao Li, Duminduni H Angappulige, Bo Zhang, Harry O'Gorman, Charles Upshur Nottingham, Anup S Shetty, Joseph E Ippolito, Gerald L Andriole, Nupam P Mahajan, Eric H Kim, Kiran Mahajan
Symptomatic Benign Prostatic Hyperplasia with Suppressed Epigenetic Regulator HOXB13 Shows a Lower Incidence of Prostate Cancer Development. Cancers 16 (1) (2024)
Duy T Nguyen, Urvashi Mahajan, Duminduni Hewa Angappulige, Aashna Doshi, Nupam P Mahajan, Kiran Mahajan
Amino Terminal Acetylation of HOXB13 Regulates the DNA Damage Response in Prostate Cancer. Cancers 16 (9) (2024)
Nimrod S Barashi, Tiandao Li, Duminduni H Angappulige, Bo Zhang, Harry O'Gorman, Charles Upshur Nottingham, Anup S Shetty, Joseph E Ippolito, Gerald L Andriole, Nupam P Mahajan, Eric H Kim, Kiran Mahajan
Symptomatic Benign Prostatic Hyperplasia with Suppressed Epigenetic Regulator HOXB13 Shows a Lower Incidence of Prostate Cancer Development. Cancers 16 (1) (2024)
Nimrod S Barashi, Tiandao Li, Duminduni H Angappulige, Bo Zhang, Harry O'Gorman, Charles Upshur Nottingham, Anup S Shetty, Joseph E Ippolito, Gerald L Andriole, Nupam P Mahajan, Eric H Kim, Kiran Mahajan
Symptomatic Benign Prostatic Hyperplasia with Suppressed Epigenetic Regulator HOXB13 Shows a Lower Incidence of Prostate Cancer Development. Cancers 16 (1) (2024)
Nimrod S Barashi, Tiandao Li, Duminduni H Angappulige, Bo Zhang, Harry O'Gorman, Charles Upshur Nottingham, Anup S Shetty, Joseph E Ippolito, Gerald L Andriole, Nupam P Mahajan, Eric H Kim, Kiran Mahajan
Symptomatic Benign Prostatic Hyperplasia with Suppressed Epigenetic Regulator HOXB13 Shows a Lower Incidence of Prostate Cancer Development. Cancers 16 (1) (2024)
Duy T Nguyen, Urvashi Mahajan, Duminduni Hewa Angappulige, Aashna Doshi, Nupam P Mahajan, Kiran Mahajan
Amino Terminal Acetylation of HOXB13 Regulates the DNA Damage Response in Prostate Cancer. Cancers 16 (9) (2024)
Nimrod S Barashi, Tiandao Li, Duminduni H Angappulige, Bo Zhang, Harry O'Gorman, Charles Upshur Nottingham, Anup S Shetty, Joseph E Ippolito, Gerald L Andriole, Nupam P Mahajan, Eric H Kim, Kiran Mahajan
Symptomatic Benign Prostatic Hyperplasia with Suppressed Epigenetic Regulator HOXB13 Shows a Lower Incidence of Prostate Cancer Development. Cancers 16 (1) (2024)
Mithila Sawant, Audrey Wilson, Dhivya Sridaran, Kiran Mahajan, Christopher J O'Conor, Ian S Hagemann, Jingqin R Luo, Cody Weimholt, Tiandao Li, Juan Carlos Roa, Akhilesh Pandey, Xinyan Wu, Nupam P Mahajan
Epigenetic reprogramming of cell cycle genes by ACK1 promotes breast cancer resistance to CDK4/6 inhibitor. Oncogene (2023)
Duy T Nguyen, Wei Yang, Arun Renganathan, Cody Weimholt, Duminduni H Angappulige, Thanh Nguyen, Robert W Sprung, Gerald L Andriole, Eric H Kim, Nupam P Mahajan, Kiran Mahajan
Acetylated HOXB13 Regulated Super Enhancer Genes Define Therapeutic Vulnerabilities of Castration-Resistant Prostate Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research 28 (18) (2022)
Mithila Sawant, Kiran Mahajan, Arun Renganathan, Cody Weimholt, Jingqin R Luo, Vandna Kukshal, Joseph M Jez, Myung Sik Jeon, Bo Zhang, Tiandao Li, Bin Fang, Yunting Luo, Nicholas J Lawrence, Harshani R Lawrence, Felix Y Feng, Nupam P Mahajan
Chronologically modified androgen receptor in recurrent castration-resistant prostate cancer and its therapeutic targeting. Science translational medicine 14 (649) (2022)